Clomipramine in phobic and obsessional states: preliminary report.
An uncontrolled trial of clomipramine for phobic and obsessional states is reported. Twenty out of 21 patients benefited.
D000328:Adult; D002997:Clomipramine / Q000009:adverse effects / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy*
D003984:Dibenzazepines; D002997:Clomipramine